Eppendorf acquires centrifuge business of Koki Holdings Co., Ltd.
Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG to expand its centrifuge business and solidifies its strong market position as one of the world’s leading makers of high-end centrifuges for the pharma and life science industries as well as academic and commercial research.
Koki Holdings will focus on developing its position as a comprehensive provider of power tools aiming to become a leading global company through strategic investment, accelerated technology and product development.
“We are excited to acquire Koki’s centrifuge business and its premium himac brand. These high-performance products are an ideal fit for Eppendorf's centrifuges business and high-quality standards,” said Dr. Peter Fruhstorfer, Co-CEO of Eppendorf AG. “With this acquisition, Eppendorf will become a full-line provider of high-performance premium centrifuges on a global level. This gives us access to new customer groups and offers opportunities for further growth.” The centrifuge business is one of Eppendorf's core businesses, Fruhstorfer continued, which will be sustainably strengthened by the acquisition.
“We are excited to have Eppendorf as a partner in acquiring our Centrifuge & Processing (C&P) business, which has held a first-place business track record in Japan for over 65 years,” said Atsushi Morisawa, CEO of Koki Holdings. “With Eppendorf’s investment through this acquisition, I am sure the Koki-originated C&P business will earn an extraordinary positioning in the global market. With that, Koki Holdings will strategically focus on the power tool industry to become the top brand globally.”
Koki Holdings Co., Ltd., develops and produces ultracentrifuges and floor-standing centrifuges under the brand name himac in Ibaraki Prefecture, Japan, which is north of Tokyo. The parties have agreed not to disclose the purchase price.
Koki Holdings Co., Ltd. was established in 1948 as manufacturer of power tools, including tools used in coal mining. In 1954, Koki began a centrifuge product business that earned a high reputation in the Japanese and global market. Koki Holdings will continue to focus on the power tools business by developing superior products and services aiming to become a leading global company in the industry.
Most read news
Other news from the department business & finance
These products might interest you

LUMiSizer by LUM
The Versatile Particle and Dispersion Analyser: At-Line, in the Process and in the Laboratory
Comprehensive analysis of nano / microparticles & their interactions in dispersions with 1 instrument

IKA G-L by IKA Werke
Sturdy and compact - discover the universal midi centrifuge
Perfect for microfiltration and cell separation

Starlab Minizentrifuge by STARLAB
The Starlab Minicentrifuge - ahead of the curve
This compact unit delivers quiet, intuitive and smooth operation along with a modern design

Analytische Ultrazentrifuge (Optima AUC) by Beckman Coulter
ideal for characterizing dispersed macromolecules and nanoparticles
combines the power of an ultracentrifuge with the functionality of optical modules

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Loving the sweet enemy - Foods rich in fats and carbohydrates stimulate the reward system in the brain particularly strong

First-in-class immunotherapies for the treatment of cancer and autoimmune diseases - ImmunOs Therapeutics Raises $74 Million Series B Financing Round
BioMed X and Boehringer Ingelheim start new joint research group
Nobilon advances first vaccine into human trials - Intranasal influenza vaccine begins Phase I clinical development
Raptor Pharmaceuticals and TorreyPines Therapeutics Receive Stockholder Approvals to Merge - Merger to Create NASDAQ-Listed Biopharmaceutical Company named Raptor Pharmaceutical Corp.

Nobel Prize for Physiology or Medicine 2020 Announced - Nobel Prize awarded to Harvey J. Alter, Michael Houghton and Charles M. Rice for the discovery of Hepatitis C virus
PharmAthene and SIGA Technologies sign definitive merger agreement
PerkinElmer announces third quarter results - GAAP Revenue of $548 million versus $563 million in the comparable prior period

Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria - Spin-out from the Universities of Glasgow and Oxford

Doped by food - Dopamine release regulates our eating behaviour

Turning fallen leaves into sustainably made paper - Ukrainian scientist selected as a finalist for the Young Inventors Prize 2024
